These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 33005933)
1. Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study. Lui GC; Yip TC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Chan HL; Hui DS; Wong GL Clin Infect Dis; 2021 May; 72(10):e466-e475. PubMed ID: 33005933 [TBL] [Abstract][Full Text] [Related]
2. Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong. Lui DTW; Chung MSH; Lau EHY; Lau KTK; Au ICH; Lee CH; Woo YC; Wong CKH; Cowling BJ JAMA Netw Open; 2023 May; 6(5):e2314393. PubMed ID: 37204790 [TBL] [Abstract][Full Text] [Related]
3. Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong. Lui DTW; Xiong X; Cheung CL; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Chung MSH; Au ICH; Lee CH; Ip TP; Woo YC; Tan KCB; Wong CKH; Wong ICK J Bone Miner Res; 2024 May; 39(5):551-560. PubMed ID: 38477768 [TBL] [Abstract][Full Text] [Related]
4. Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong. Luk AOY; Yip TCF; Zhang X; Kong APS; Wong VW; Ma RCW; Wong GL BMJ Open; 2021 Oct; 11(10):e052310. PubMed ID: 34670765 [TBL] [Abstract][Full Text] [Related]
5. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471 [TBL] [Abstract][Full Text] [Related]
6. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi. Aggarwal A; Shrivastava A; Kumar A; Ali A J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676 [TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome (SARS) and coronavirus disease-2019 (COVID-19): From causes to preventions in Hong Kong. Law S; Leung AW; Xu C Int J Infect Dis; 2020 May; 94():156-163. PubMed ID: 32251790 [TBL] [Abstract][Full Text] [Related]
8. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Choi KW; Chau TN; Tsang O; Tso E; Chiu MC; Tong WL; Lee PO; Ng TK; Ng WF; Lee KC; Lam W; Yu WC; Lai JY; Lai ST; Ann Intern Med; 2003 Nov; 139(9):715-23. PubMed ID: 14597455 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
10. A Comparison Between Chinese Children Infected with Coronavirus Disease-2019 and with Severe Acute Respiratory Syndrome 2003. Xiong X; Chua GT; Chi S; Kwan MYW; Sang Wong WH; Zhou A; Shek CC; Tung KTS; Qin H; Wong RS; Li X; Chen P; Li S; Chui CS; Tso WWY; Ho MHK; Wong ICK; Chan GCF; Lau YL; Wong KKY; Chung PHY; Li H; Tam PKH; Tang ST; Ip P J Pediatr; 2020 Sep; 224():30-36. PubMed ID: 32565097 [TBL] [Abstract][Full Text] [Related]
11. Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong. Wong CKH; Lui DTW; Lui AYC; Kwok ACY; Low MCH; Lau KTK; Au ICH; Xiong X; Chung MSH; Lau EHY; Cowling BJ Diabetes Metab; 2022 Jan; 48(1):101307. PubMed ID: 34863934 [TBL] [Abstract][Full Text] [Related]
12. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study. Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927 [TBL] [Abstract][Full Text] [Related]
13. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT. Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330 [TBL] [Abstract][Full Text] [Related]
14. Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong. Fan FSY; Yip TCF; Yiu B; Lam B; Au L; Lau AY; Ip B; Soo Y; Leung TW; Li T; Lui G; Wong GLH; Mok V J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1356-1358. PubMed ID: 33906935 [No Abstract] [Full Text] [Related]
15. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Leung GM; Hedley AJ; Ho LM; Chau P; Wong IO; Thach TQ; Ghani AC; Donnelly CA; Fraser C; Riley S; Ferguson NM; Anderson RM; Tsang T; Leung PY; Wong V; Chan JC; Tsui E; Lo SV; Lam TH Ann Intern Med; 2004 Nov; 141(9):662-73. PubMed ID: 15520422 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022. Mefsin YM; Chen D; Bond HS; Lin Y; Cheung JK; Wong JY; Ali ST; Lau EHY; Wu P; Leung GM; Cowling BJ Emerg Infect Dis; 2022 Sep; 28(9):1856-1858. PubMed ID: 35914518 [TBL] [Abstract][Full Text] [Related]
17. Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of the outbreak in Hong Kong in 2020. Ran J; Zhao S; Zhuang Z; Chong MKC; Cai Y; Cao P; Wang K; Lou Y; Wang W; Gao D; Yang L; He D; Wang MH Int J Infect Dis; 2020 Jul; 96():284-287. PubMed ID: 32413609 [TBL] [Abstract][Full Text] [Related]
18. A major outbreak of severe acute respiratory syndrome in Hong Kong. Lee N; Hui D; Wu A; Chan P; Cameron P; Joynt GM; Ahuja A; Yung MY; Leung CB; To KF; Lui SF; Szeto CC; Chung S; Sung JJ N Engl J Med; 2003 May; 348(20):1986-94. PubMed ID: 12682352 [TBL] [Abstract][Full Text] [Related]
19. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662 [TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]